PMID: 9544235Apr 17, 1998Paper

HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis

Human Immunology
M YuV K Tuohy

Abstract

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system. It is widely believed that complex polygenic inheritance patterns involving HLA-DR and -DQ class II genes contribute to MS susceptibility, and current evidence indicates that disease risk vs disease outcome may be associated with distinctly different HLA class II alleles. We have recently shown that the early development of MS is accompanied by an extensive plasticity of myelin self-recognition with the acquisition of neo-autoreactivity, or epitope spreading, as a prominent feature. Although we did not observe a common determinant recognized by patients sharing identical HLA-DR or -DQ class II alleles, we did observe epitope spreading to the p50-63 determinant of myelin proteolipid protein (PLP) in two study subjects showing complete disparity at HLA-DR and -DQ but identity at the HLA-DP allele DPB1*0301. In the present study we show that self-recognition during the early stages in the development of MS involves HLA-DP class II restricted responses to the PLP 50-63 spreading determinant. Our results suggest that self-presentation by HLA-DP may play an important role in epitope spreading and in the propagation of self-recognition during...Continue Reading

References

Jan 1, 1992·Annual Review of Immunology·R MartinD E McFarlin
Oct 1, 1991·Human Immunology·D A FrancisJ R Batchelor
Aug 1, 1991·Immunology Today·K W WucherpfennigD A Hafler
Dec 11, 1987·Science·J NovotnyE Haber
Jan 1, 1987·Journal of Neuroscience Research·W B MacklinM V Gardinier
Mar 1, 1989·Journal of Neuroimmunology·C N BaxevanisM Papamichail
Jun 1, 1989·Journal of Neuroimmunology·J R RichertM W Kies
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·O OlerupJ Wallin
Aug 1, 1986·Human Immunology·C GorodezkyJ Sotelo
Apr 1, 1988·Neurology·B A Yaqub, A K Daif
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Jul 15, 1995·The Journal of Immunology : Official Journal of the American Association of Immunologists·S Markovic-PleseD A Hafler
Jan 1, 1993·Annual Review of Immunology·E E SercarzK Moudgil
Jan 1, 1996·Disease-a-month : DM·S G Lynch, J W Rose
May 1, 1996·Diabetes·H A ErlichA Zeidler
Apr 1, 1997·The Journal of Clinical Investigation·V K TuohyR P Kinkel

❮ Previous
Next ❯

Citations

Sep 15, 2005·Journal of Clinical Immunology·Junbao YangWilliam W Kwok
Apr 23, 2004·Trends in Molecular Medicine·Bert A 't HartErwin Blezer
Apr 12, 2001·British Journal of Haematology·E W PetersdorfJ A Hansen
Apr 20, 2002·Transplantation·Anna ValujskikhPeter S Heeger
Jan 17, 2004·Clinical Microbiology Reviews·Emilia L OleszakChris D Platsoucas
Mar 18, 2005·Annual Review of Immunology·Mireia Sospedra, Roland Martin
Jun 16, 2000·Journal of Neuroimmunology·S S WilsonE E Sercarz
Jul 9, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S SotgiuG Rosati
Apr 2, 2009·Journal of Neuropathology and Experimental Neurology·Bert A 't Hart, Luca Massacesi
Dec 8, 2004·Social Psychiatry and Psychiatric Epidemiology·Susan M Becker
Jan 13, 2004·Clinical and Diagnostic Laboratory Immunology·Lazaros I SakkasChris D Platsoucas
Jul 24, 2002·Tissue Antigens·M BengtssonU Johansson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.